Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - May 2013

6th Imaging in Drug Discovery & Development

08 May 2013 - 10 May 2013 - Boston, MA, USA

Bookmark and Share

GTC's 6th Imaging in Drug Discovery and Development conference, one of four parallel tracks of the 2nd Novel Technologies in Drug Discovery Summit on May 8-10, 2013 in Boston, MA, is the only imaging conference that brings together high-level/influential leaders with decision-making authority from the pharmaceutical industry, academia, and government to share their knowledge and expertise in drug discovery and development . Our approach offers a more intimate and networking-oriented environment that is geared towards connecting scientists and researchers who use single- and multimodal imaging applications to further collaborate and advance their imaging projects in drug discovery and development. 

Session topics include: 

Advantages and Challenges of Available Imaging Modalities

Translational Imaging Applications: Preclinical to Clinical 

Imaging Applications Across Multiple Therapeutic Areas 

Molecular Imaging and Diagnostic Approaches and Capabilities 

High Content Imaging, Quantitative Imaging and Modeling Capabilities

The conference will run parallel with the other exciting conferences:

8th Assay and Drug Discovery Technologies

7th Drug Design and Medicinal Chemistry

3rd Next Generation Sequencing

Orphan Drugs Research and Commercialization

Sign up for the summit pass and get access to all 5 tracks in the summit! Or register 3 attendees for the price of 2 by entering coupon code rcdvb when you sign up!

We look forward to seeing you at the 6th Imaging in Drug Discovery and Development Conference!


Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos